HealthPhoto: Hindustan TimesGovernment Caps Trade Margin on 137 Cancer Drugs at 30%
The National Pharmaceutical Pricing Authority (NPPA) has capped the trade margin on 137 non-scheduled anti-cancer drugs at 30% of their maximum retail price (MRP). This move, effective from November 9, aims to reduce prices by up to 70%. The decision was made under Paragraph 19 of the Drugs (Prices Control) Order, 2013, to address excessive trade mark-ups and protect public interest.
Hindustan Times·

